These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9168689)

  • 1. Monoamine oxidase inhibitor overdose.
    Thorp M; Toombs D; Harmon B
    West J Med; 1997 Apr; 166(4):275-7. PubMed ID: 9168689
    [No Abstract]   [Full Text] [Related]  

  • 2. Overdose with moclobemide.
    Heinze G; Sanchez A
    J Clin Psychiatry; 1986 Aug; 47(8):438. PubMed ID: 3733681
    [No Abstract]   [Full Text] [Related]  

  • 3. Loss of antidepressant effect with long-term monoamine oxidase inhibitor treatment without loss of monoamine oxidase inhibition.
    Mann JJ
    J Clin Psychopharmacol; 1983 Dec; 3(6):363-6. PubMed ID: 6315778
    [No Abstract]   [Full Text] [Related]  

  • 4. Discrimination Between Drug Abuse and Medical Therapy: Case report of a tranylcypromine overdose-related fatality.
    Akhgari M; Jokar F; Etemadi-Aleagha A; Ghasemi A
    Sultan Qaboos Univ Med J; 2017 May; 17(2):e213-e217. PubMed ID: 28690895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One fatal and one nonfatal intoxication with tranylcypromine. Absence of amphetamines as metabolites.
    Iwersen S; Schmoldt A
    J Anal Toxicol; 1996 Sep; 20(5):301-4. PubMed ID: 8872238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin syndrome with severe hyperthermia after ingestion of tranylcypromine combined with serotonin reuptake inhibitors and tyramine-rich food in a case of suicide.
    Degner D; Porzig J; Rüther E; von Lewinski D
    Pharmacopsychiatry; 2010 Nov; 43(7):284-5. PubMed ID: 20830665
    [No Abstract]   [Full Text] [Related]  

  • 8. Tranylcypromine ('Parnate') overdose: measurement of tranylcypromine concentrations and MAO inhibitory activity and identification of amphetamines in plasma.
    Youdim MB; Aronson JK; Blau K; Green AR; Grahame-Smith DG
    Psychol Med; 1979 May; 9(2):377-82. PubMed ID: 472083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced hyperpyrexia. A case report.
    King J; Barnett PS; Kew MC
    S Afr Med J; 1979 Aug; 56(5):190-1. PubMed ID: 550464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ping Pong gaze in reversible coma due to overdose of monoamine oxidase inhibitor.
    Watkins HC; Ellis CJ
    J Neurol Neurosurg Psychiatry; 1989 Apr; 52(4):539. PubMed ID: 2738599
    [No Abstract]   [Full Text] [Related]  

  • 11. [Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases].
    Oostervink F; Bouvy PF; Touw DJ
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1937-40. PubMed ID: 14574773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of moclobemide taken in overdose for attempted suicide.
    Hetzel W
    Psychopharmacology (Berl); 1992; 106 Suppl():S127-9. PubMed ID: 1546127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peaked "T" waves with tranylcypromine (parnate) overdose.
    Quill TE
    Int J Psychiatry Med; 1981-1982; 11(2):155-60. PubMed ID: 7263132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranylcypromine withdrawal phenomena.
    Halle MT; Dilsaver SC
    J Psychiatry Neurosci; 1993 Jan; 18(1):49-50. PubMed ID: 8461282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
    Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T
    Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and treatment of overdosage of monoamine oxidase inhibitors and their interaction with other psychotropic drugs.
    Ciocatto E; Fagiano G; Bava GL
    Resuscitation; 1972 Mar; 1(1):69-72. PubMed ID: 4653029
    [No Abstract]   [Full Text] [Related]  

  • 17. Sisyphus on the rocks--monoamine oxidase inhibitors.
    Mack RB
    N C Med J; 1985 Jul; 46(7):429-30. PubMed ID: 3861951
    [No Abstract]   [Full Text] [Related]  

  • 18. MAO inhibition as antidepressive mechanism reevaluated. A controlled study with tranylcypromine isomers.
    Beckmann H; Moises HW
    Mod Probl Pharmacopsychiatry; 1983; 19():211-4. PubMed ID: 6865965
    [No Abstract]   [Full Text] [Related]  

  • 19. "Ping-pong" gaze in severe monoamine oxidase inhibitor toxicity.
    Erich JL; Shih RD; O'Connor RE
    J Emerg Med; 1995; 13(5):653-5. PubMed ID: 8530785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoresistant convulsions and visual hallucinations around two weeks after selegiline overdose: a case report.
    Kobayashi T; Saito N; Suda S; Shioda K; Kato S
    Pharmacopsychiatry; 2011 Nov; 44(7):346-7. PubMed ID: 21989600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.